Selected research
Industry Growth & Trends
Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market include Takeda, Jiangsu Hengrui Medicine Co Ltd, Jiangsu Nhwa Pharmaceutical Corp Ltd, Pfizer Inc, Primex Pharmaceuticals Oy and Paion AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Gamma-Aminobutyric Acid Receptor Subunit Gamma 2.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market by Company
Takeda
Jiangsu Hengrui Medicine Co Ltd
Jiangsu Nhwa Pharmaceutical Corp Ltd
Pfizer Inc
Primex Pharmaceuticals Oy
Paion AG
Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Segment by Type
EL-001
Midazolam Hydrochloride
LASSBio-786
LASSBio-785
Others
Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Segment by Application
Insomnia
General Anesthetic Effect
Hypertension
Others
Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- EL-001
- Midazolam Hydrochloride
- LASSBio-786
- LASSBio-785
- Others
Applications
- Insomnia
- General Anesthetic Effect
- Hypertension
- Others
Companies covered
- Takeda
- Jiangsu Hengrui Medicine Co Ltd
- Jiangsu Nhwa Pharmaceutical Corp Ltd
- Pfizer Inc
- Primex Pharmaceuticals Oy
- Paion AG
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Region (2021-2032)
- 1.4.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Region (2021-2026)
- 1.4.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Region (2027-2032)
- 1.5 Key Regions Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size (2021-2032)
- 1.5.1 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Growth Rate (2021-2032)
- 1.5.4 South America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Growth Rate (2021-2032)
2 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market by Type
- 2.1 Type Introduction
- 2.1.1 EL-001
- 2.1.2 Midazolam Hydrochloride
- 2.1.3 LASSBio-786
- 2.1.4 LASSBio-785
- 2.1.5 Others
- 2.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Type
- 2.2.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Overview by Type (2021-2032)
- 2.2.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Forecasted by Type (2027-2032)
- 2.3 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Regions
- 2.3.1 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Breakdown by Type (2021-2026)
3 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market by Application
- 3.1 Type Introduction
- 3.1.1 Insomnia
- 3.1.2 General Anesthetic Effect
- 3.1.3 Hypertension
- 3.1.4 Others
- 3.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Application
- 3.2.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Overview by Application (2021-2032)
- 3.2.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Forecasted by Application (2027-2032)
- 3.3 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Regions
- 3.3.1 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Industry Trends
- 4.2 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Industry Drivers
- 4.3 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Industry Opportunities and Challenges
- 4.4 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue (2021-2026)
- 5.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Key Company Headquarters & Area Served
- 5.4 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Company, Product Type & Application
- 5.5 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Players Market Share by Revenue in 2025
- 5.6.3 2025 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Takeda
- 6.1.1 Takeda Company Information
- 6.1.2 Takeda Business Overview
- 6.1.3 Takeda Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Takeda Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio
- 6.1.5 Takeda Recent Developments
- 6.2 Jiangsu Hengrui Medicine Co Ltd
- 6.2.1 Jiangsu Hengrui Medicine Co Ltd Company Information
- 6.2.2 Jiangsu Hengrui Medicine Co Ltd Business Overview
- 6.2.3 Jiangsu Hengrui Medicine Co Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Jiangsu Hengrui Medicine Co Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio
- 6.2.5 Jiangsu Hengrui Medicine Co Ltd Recent Developments
- 6.3 Jiangsu Nhwa Pharmaceutical Corp Ltd
- 6.3.1 Jiangsu Nhwa Pharmaceutical Corp Ltd Company Information
- 6.3.2 Jiangsu Nhwa Pharmaceutical Corp Ltd Business Overview
- 6.3.3 Jiangsu Nhwa Pharmaceutical Corp Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Jiangsu Nhwa Pharmaceutical Corp Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio
- 6.3.5 Jiangsu Nhwa Pharmaceutical Corp Ltd Recent Developments
- 6.4 Pfizer Inc
- 6.4.1 Pfizer Inc Company Information
- 6.4.2 Pfizer Inc Business Overview
- 6.4.3 Pfizer Inc Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Pfizer Inc Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio
- 6.4.5 Pfizer Inc Recent Developments
- 6.5 Primex Pharmaceuticals Oy
- 6.5.1 Primex Pharmaceuticals Oy Company Information
- 6.5.2 Primex Pharmaceuticals Oy Business Overview
- 6.5.3 Primex Pharmaceuticals Oy Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Primex Pharmaceuticals Oy Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio
- 6.5.5 Primex Pharmaceuticals Oy Recent Developments
- 6.6 Paion AG
- 6.6.1 Paion AG Company Information
- 6.6.2 Paion AG Business Overview
- 6.6.3 Paion AG Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Paion AG Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio
- 6.6.5 Paion AG Recent Developments
7 North America
- 7.1 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Country (2021-2026)
- 7.3 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Country (2021-2026)
- 8.3 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Country (2021-2026)
- 10.3 South America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst